Weight loss drugs are gaining popularity among workers with job-based insurance, but their high costs are causing employers ...

Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and ...

Dr. Cabandugama said unlike GLP-1 medications, weight-loss supplements do not need to be approved for use by the FDA. That ...

Employer-based health insurance plans are expected to rise again for 2026. Here's what's behind the high costs.

Boothwyn Pharmacy in Kennett Square made 30,000 doses of injectable medicine at a facility that wasn't inspected, officials ...

Despite the exciting promise that emerged from these studies, the company that funded the work did not allow the researcher ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

Boothwyn Pharmacy in Chester County is facing a $1 million fine for compounding GLP-1 medications in uninspected facilities.

The firm appointed Benjamin Cordonnier as CEO and co-managing partner, and Judith Charpentier as co-managing partner in May.

A pharmacy in Chester County was fined $1 million producing around 30,000 doses of an injectable weight-loss drug without ...

Boothwyn Pharmacy in Chester County is facing a $1 million fine for compounding GLP-1 medications in uninspected facilities.

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study ...